Shandong Buchang Pharmaceuticals Co (SHSE:603858) Other Operating Expense: ¥767 Mil (TTM As of Jun. 2026)

Author:

Vera Yuan

Director of Data and Quant Analytics at GuruFocus

Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.

View Profile →

Reviewed by:

Charlie Tian

Founder & CEO of GuruFocus

Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

View Profile →

Shandong Buchang Pharmaceuticals Co Ltd SHSE:603858

71 GF Score

Price ¥14.85

GF Value ¥15.36

Valuation Fairly Valued

6 Warning Signs

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

What is Shandong Buchang Pharmaceuticals Co Other Operating Expense?

Shandong Buchang Pharmaceuticals Co SHSE:603858 71 Other Operating Expense is ¥767 Mil as of Jun. 2026. GuruFocus rates SHSE:603858 with a GF Score™ of 71/100 and a GF Value™ of ¥15.36 (Fairly Valued). The stock has 6 warning signs investors should review.

Shandong Buchang Pharmaceuticals Co's Other Operating Expense for the three months ended in Jun. 2026 was ¥338 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 was ¥767 Mil.

Shandong Buchang Pharmaceuticals Co's quarterly Other Operating Expense declined from Dec. 2025 (¥702 Mil) to Mar. 2026 (¥25 Mil) but then increased from Mar. 2026 (¥25 Mil) to Jun. 2026 (¥338 Mil).

Shandong Buchang Pharmaceuticals Co's annual Other Operating Expense declined from Dec. 2023 (¥986 Mil) to Dec. 2024 (¥956 Mil) and declined from Dec. 2024 (¥956 Mil) to Dec. 2025 (¥759 Mil).

Try GuruFocus Premium free for 7 days

Unlock GF Score, GF Value, 30-Y financials, and pro screeners.

Get Started →

Shandong Buchang Pharmaceuticals Co Other Operating Expense Related Terms

Shandong Buchang Pharmaceuticals Co Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Shandong Buchang Pharmaceuticals Co's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shandong Buchang Pharmaceuticals Co Other Operating Expense Chart

Shandong Buchang Pharmaceuticals Co Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Other Operating Expense

Get a 7-Day Free Trial

937.35

1,050.33

986.39

956.16

758.61

Shandong Buchang Pharmaceuticals Co Quarterly Data
	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26	Jun26
Other Operating Expense	Get a 7-Day Free Trial															340.62	-297.79	702.22	24.57	338.25

71GF Score

Shandong Buchang Pharmaceuticals Co Ltd SHSE:603858

Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →

Shandong Buchang Pharmaceuticals Co Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥767 Mil.

Frequently Asked Questions Learn more about Other Operating Expense →

What does a Other Operating Expense of ¥767 Mil mean?

Shandong Buchang Pharmaceuticals Co (SHSE:603858) has a Other Operating Expense of ¥767 Mil as of Jun. 2026. Other operating expenses that a company records on its income statement. View historical data on Shandong Buchang Pharmaceuticals Co and its competitors.

Is Shandong Buchang Pharmaceuticals Co's Other Operating Expense too high?

Shandong Buchang Pharmaceuticals Co's current Other Operating Expense is ¥767 Mil. Overall, Shandong Buchang Pharmaceuticals Co has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.

How does Shandong Buchang Pharmaceuticals Co's Other Operating Expense compare to ZTS?

Shandong Buchang Pharmaceuticals Co's Other Operating Expense of ¥767 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Other Operating Expense for a Drug Manufacturers company?

A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Other Operating Expense mean?

A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Shandong Buchang Pharmaceuticals Co and its competitors. Shandong Buchang Pharmaceuticals Co's current Other Operating Expense is ¥767 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Shandong Buchang Pharmaceuticals Co stock overvalued right now?

Based on GuruFocus' analysis, Shandong Buchang Pharmaceuticals Co (SHSE:603858) is currently considered Fairly Valued. The stock's GF Value™ is ¥15.36, compared to a current price of ¥14.85 — trading 3.3% below its estimated fair value. The current Other Operating Expense is ¥767 Mil. Shandong Buchang Pharmaceuticals Co's overall GF Score™ is 71/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Other Operating Expense calculated?

Other Operating Expense is calculated from a company's financial statements. For Shandong Buchang Pharmaceuticals Co (SHSE:603858), the current Other Operating Expense is ¥767 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shandong Buchang Pharmaceuticals Co (SHSE:603858) Overvalued in 2026?

Based on GuruFocus' analysis, Shandong Buchang Pharmaceuticals Co stock appears to be undervalued. The current stock price of ¥14.85 is trading 3.3% below its estimated GF Value™ of ¥15.36. GuruFocus considers Shandong Buchang Pharmaceuticals Co to be Fairly Valued.

Key valuation signals for SHSE:603858:

Other Operating Expense: ¥767 Mil
GF Value™: ¥15.36 vs. price of ¥14.85 (3.3% below fair value)
GF Score™: 71/100 with 6 warning signs

No single metric tells the full story. See the SHSE:603858 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Start Your Free 7-Day GuruFocus Premium Trial

Unlock 30-Y financials, GF Score, and 150+ pro screeners →